Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: colon  intestine  constipation  flu  vaccine  health  healthcare  fluzone  fda  pharmacies  sanofi  medical  multivu  7842051  vitamin  d  calcium  vitamin  d  and  calcium  abbott  idesign  nasa  lasik  hubble  telescope  james  webb  space  eye  vision  multivu  7571951  mark  wahlberg  millennium  health  prescription  drugs  medicine  medication  misuse  abuse  teens  kids  multivu  7071752  heaven  hell  god  bible  jesus  faith  spirituality  mickey  rourke  bullet  1996  bullet  1996  crazy  gun  crack  drugs  diabetes  diabetic  blood  glucose  meter  glucose  accuchek  accucheck  aviva  expert  health  blood  sugar  insulin  healthcare  mult  astellas  innovation  debate  2015  george  freeman  medicine  health  united  kingdom  healthcare  multivu  7423951  livanova  medical  technology  therapy  health  treatment  drug  vns  epilepsy  multivu  7966451  acid  reflux  how  to  get  rid  of  acid  reflux  how  to  reduce  acid  reflux  quickly  how  to  cure  acid  reflux  naturally  zensun  neucardin  chronic  congestive  heart  failure  chf  disease  treatment  research  multivu  61677 
Search // drug
Results 121-132 of 137 for ' drug ' (1 seconds)
Earth, 2144. Jack is an anti-patent scientist turned drug pirate, traversing the world in a submarine as a pharmaceutical Robin Hood, fabricating cheap scrips for poor people who can’t otherwise afford them. But her latest drug hack has left a trail of lethal overdoses as people become addicted to their work, doing repetitive tasks until they become unsafe or insane. Find out more at- https://us.macmillan.com/books/9780765392077 Fantasy/scifi
Categories // Miscellaneous 
Added: 2757 days ago by cosproductions
Runtime: 1m3s | Views: 1046 | Comments: 1
Not yet rated
 

 

 

Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today. Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated. To view the multimedia release go to: https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Categories // Miscellaneous 
Added: 2960 days ago by MultiVuVideos
Runtime: 1m0s | Views: 1038 | Comments: 2
Not yet rated
 

 

 

A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma. The novel drug to treat malignant glioma, notorious for recurring after typical bouts of standard cancer treatment, was developed by a Northwestern scientist and has been approved as an investigational drug by the U.S. Food and Drug Administration. This is only the second time the University has supported and filed an investigational new drug as a sponsor. To view the multimedia release go to: https://www.multivu.com/players/English/7944251-northwestern-medicine-stem-cell-trial/
Categories // Miscellaneous 
Added: 3043 days ago by MultiVuVideos
Runtime: 4m28s | Views: 994 | Comments: 0
Not yet rated
 

 

 

According to a National Safety Council poll released today, one in four Americans personally knows someone who has overdosed or died from an opioid overdose, knows someone who has become addicted to opioids, or has become addicted themselves. In response to the survey results – and a recommendation from the President’s Commission for Combating Drug Addiction and the Opioid Crisis – the National Safety Council is launching a provocative nationwide public education campaign that literally puts a face on the opioid epidemic. Stericycle is the Council’s exclusive disposal partner on the campaign. To view the multimedia release go to: https://www.multivu.com/players/English/8207151-national-safety-council-stop-everyday-killers-opioids/
Categories // Miscellaneous 
Added: 2903 days ago by MultiVuVideos
Runtime: 2m56s | Views: 984 | Comments: 1
Not yet rated
 

 

 

Express Scripts clinical innovations saved its clients $45 billion in 2018 and delivered a 25-year record low drug trend of just 0.4 percent across employer-sponsored plans, according to data released today in its annual Drug Trend Report, an authoritative analysis of drug spending in the U.S. Express Scripts’ solutions for driving lower drug prices and fostering the use of lower-net-cost treatments are making medication more accessible for beneficiaries. Unit drug costs decreased in 2018 for employer-sponsored and Medicare plans, while utilization of medications rose. To view the multimedia release go to: https://www.multivu.com/players/English/8478051-express-scripts-2018-drug-trend-report/
Categories // Miscellaneous 
Added: 2449 days ago by MultiVuVideos
Runtime: 1m5s | Views: 981 | Comments: 0
Not yet rated
 

 

 

Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease. With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months. The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers. To view the multimedia release go to: http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
Categories // Science and Technology 
Added: 3669 days ago by MultiVuVideos
Runtime: 0m45s | Views: 970 | Comments: 0
Not yet rated
 

 

 

EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
Added: 3933 days ago by MultiVuVideos
Runtime: 0m24s | Views: 959 | Comments: 0
Not yet rated
 

 

 

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, introduces today its latest innovation, the Cochlear™ Nucleus® 7 Sound Processor. Approved by the U.S. Food and Drug Administration (FDA) in June, the Nucleus 7 Sound Processor is the world’s first Made for iPhone cochlear implant sound processor and the smallest and lightest behind-the-ear cochlear implant sound processor available on the market.1-3 With the Nucleus 7 Sound Processor, people with a Cochlear Nucleus Implant can now stream sound directly from a compatible iPhone, iPad and iPod touch directly to their sound processor.4,5* They will also be able to control, monitor and customize their hearing on their iPhone or iPod touch through the Nucleus® Smart App available to download for free from the App Store®. To view the multimedia release go to: https://www.multivu.com/players/English/7987851-cochlear-nucleus-7-sound-processor/
Categories // Miscellaneous 
Added: 3009 days ago by MultiVuVideos
Runtime: 0m45s | Views: 950 | Comments: 0
Not yet rated
 

 

 

In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community. St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature. “Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.” To view the multimedia release go to: https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
Categories // Miscellaneous 
Added: 2973 days ago by MultiVuVideos
Runtime: 1m34s | Views: 951 | Comments: 0
Not yet rated
 

 

 

Partnership for Drug-Free Kids, the nation’s leading nonprofit committed to helping families struggling with their son’s or daughter’s substance use, today announced that it has extended the hours of its free Parent Helpline. The bilingual Helpline is staffed by Parent Support Specialists, trained and caring Master’s-level counselors, who are ready to listen, help parents find answers and make an action plan for their child. Parent Support Specialists offer parents and caregivers the support and resources needed to care for a loved one who is struggling with substances. Families can connect with the Helpline via the website, drugfree.org, by phone at 855-DRUGFREE, through text messaging and Facebook Messenger. Help is available in English and Spanish. To view the multimedia release go to: https://www.multivu.com/players/English/8253451-partnership-for-drug-free-kids-extends-parent-helpline-hours/
Tags // drugs  kids  helpline  drug  free  phone  hotline  call  spanish  help  multivu  8253451 
Categories // Miscellaneous 
Added: 2498 days ago by MultiVuVideos
Runtime: 2m41s | Views: 939 | Comments: 1
Not yet rated
 

 

 

The winter of 2016-2017 is in its early stages, and yet many parts of the country are already experiencing extreme weather conditions and power outages. In fact, a power outage can happen at any time, and it can affect the safety of your food. The U.S. Food and Drug Administration reminds you that the best way to ensure that food stays safe is to have a plan in place, and to know what food safety precautions to take if a power outage does occur. To view the multimedia release go to: http://www.multivu.com/players/English/7876851-fda-power-outage-food-safety-2016/
Categories // Miscellaneous 
Added: 3246 days ago by MultiVuVideos
Runtime: 2m45s | Views: 935 | Comments: 0
Not yet rated
 

 

 

West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC, today announced the completion of the first two phases of their four-phase strategic collaboration. The companies are working to integrate HealthPrize’s Software-as-a-Service (SaaS) medication adherence and patient-engagement platform with West’s injectable drug delivery systems to provide an end-to-end connected health solution for pharmaceutical companies and the patients they serve. The combined offering will provide voluntary, electronically connected drug delivery systems that track when patients take their medication. The HealthPrize system engages and educates patients to increase adherence and medical literacy, rewarding interaction and compliance with prescribed treatment plans, and contributing to better health outcomes. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7625851-west-pharma-healthprize-tech-collaboration/
Categories // Business  Science and Technology 
Added: 3687 days ago by MultiVuVideos
Runtime: 3m20s | Views: 917 | Comments: 0
Not yet rated
 

 

 

Page 11 of 12  |  Go to page     |  ««FIRST «Previous  Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2025 ClipMoon.com. All rights reserved.